California's Biotech Supercharge: Biocom & Octane Forge Alliance

SAN DIEGO & NEWPORT BEACH, CA – March 17, 2026 – In a landmark move poised to accelerate innovation across California's world-leading life science sector, Biocom and Octane today announced a strategic partnership designed to create a more powerful and unified ecosystem for biotechnology and medical technology companies. The collaboration merges the strengths of Biocom, the state's largest life science membership association, and Octane, a premier technology and medtech accelerator, forging a comprehensive pipeline from early-stage innovation to global commercialization.

This alliance aims to dismantle existing barriers for entrepreneurs by expanding access to critical capital, elite accelerator programs, and extensive industry networks. By creating what both organizations describe as a “single, coordinated path,” the partnership seeks to streamline the often-arduous journey for startups, reinforcing California's dominance in a global industry.

“Biocom and Octane each bring unique strengths to the life science and medtech innovation ecosystems,” said Tim Scott, president and CEO of Biocom, in a statement. “By bringing together Octane’s accelerator and investor networks with Biocom’s life science community, we are creating new pathways for entrepreneurs to access capital, partnerships and growth opportunities.”

A Synergistic Approach to a Statewide Powerhouse

The partnership represents a calculated fusion of scale and specialization. Biocom, representing over 1,700 member organizations, provides a vast platform for industry-wide advocacy, workforce development, and significant operational cost savings. This broad support structure will now be directly integrated with Octane’s targeted, high-intensity approach to company building. Octane has a proven track record, with its portfolio companies having raised over $12.1 billion in capital since 2010.

This synergy is designed to supercharge an already formidable economic engine. In 2024, California's life science industry supported 1.15 million jobs and generated an astounding $395.7 billion in economic output. The collaboration between these two influential bodies is expected to amplify that impact by making the innovation process more efficient.

“Octane and Biocom share a common mission: to help innovative companies start, grow and scale,” noted Bill Carpou, CEO of Octane. “Octane’s track record of guiding companies from concept to commercialization, combined with Biocom’s industry influence and connectivity, will accelerate the development and deployment of new life science and medtech technologies.”

Uniting California's Diverse Innovation Hubs

A key strategic objective of the alliance is to bridge the geographic and logistical divides between California's various life science clusters. While hubs like the San Francisco Bay Area and San Diego are globally recognized, the partnership places a significant emphasis on integrating Orange County's robust medtech sector more deeply into the statewide network.

Orange County is a quiet giant in the industry, particularly in medical devices and diagnostics. The region boasted nearly 61,000 life science workers and contributed $44.8 billion in economic output in 2024, housing major players like Edwards Lifesciences. The partnership will see Biocom extend its global network more formally into Orange County, where Octane is already a deeply embedded and influential player. In return, Octane’s local network of innovators gains unprecedented access to Biocom’s statewide and international resources.

This move addresses a subtle but important gap. While Orange County saw the establishment of nearly 40 new medical device businesses in 2023, the region also experienced a slight dip in overall sector employment. By creating stronger connective tissue to the broader California ecosystem, the partnership aims to provide the support network necessary to ensure these new ventures not only survive but thrive and generate high-quality jobs, solidifying the region's innovative capacity.

A Game Changer for Startups and Entrepreneurs

For individual entrepreneurs and early-stage companies, the collaboration offers immediate and tangible benefits. In a significant gesture of integration, companies accepted into Octane's prestigious LaunchPad accelerator will now receive a one-year complimentary membership to Biocom.

This single benefit unlocks a suite of resources that can be transformative for a nascent company. Access to Biocom's Group Purchasing programs, for instance, can save a small company with fewer than 50 employees over $90,000 annually on essential lab supplies and business services—capital that can be redirected toward critical research and development. Furthermore, these startups will gain a powerful voice in Sacramento and Washington, D.C., through Biocom’s seasoned policy and advocacy arm.

The benefits are reciprocal. Biocom's vast membership of emerging and growth-stage companies will gain preferred access to Octane's industry-leading conferences and, most importantly, its curated network of investors. Octane will work directly with Biocom to identify high-potential companies and prepare them for the rigors of fundraising and strategic partnership negotiations. This effectively creates a dedicated on-ramp to capital and mentorship for Biocom members, fulfilling a core part of its mission to foster growth.

By leveraging their combined networks and expertise, the two organizations aim to speed the development and commercialization of breakthrough technologies. While Biocom and Octane will remain independent entities, their collaborative initiatives are set to strengthen connections across California’s major innovation hubs, creating a more connected and efficient pipeline from the laboratory bench to the patient bedside.